Share Name Share Symbol Market Type Share ISIN Share Description
Silence Therapeutics Plc LSE:SLN London Ordinary Share GB00B9GTXM62 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -0.45% 438.00 428.00 434.00 446.00 428.00 440.00 58,462 16:35:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -20.5 -26.2 - 342

Silence Therapeutics Share Discussion Threads

Showing 50376 to 50400 of 50950 messages
Chat Pages: Latest  2026  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  Older
DateSubjectAuthorDiscuss
04/10/2018
16:59
Will listen tonight. Makes you wonder why SLN are so ridiculously underperforming the sector - management changes, legal battles? In the next 3 months we have the Quark phase 3 results, the filing of the new trial drug and the legal action re Patisiran on 10th December so plenty newsflow.
callumross
04/10/2018
16:14
"Billion plus"? Did anyone else listen to the CEO's presentation at Cantor Fitzgerald? hTtps://www.silence-therapeutics.com/news-media/events/ Right at the end there's a bullish comment something like: "So that's why companies like Arrowhead, like Dicerna, are ramping up to the billion plus, and I think we'll not be far behind...simply because people see value, they see safety etc and they see a validated class in the pharmacopeia."
1gw
04/10/2018
15:16
Whoops. On the plus side, along with recent Alnylam updates the area seems to have some renewed interest.
waterloo01
04/10/2018
15:11
"J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion" "J&J will make a $75 million equity investment in Arrowhead at $23 per share, a premium of about 24 percent to the stock's Wednesday close. Arrowhead will also get $175 million upfront, the company said in a statement." hTtps://uk.finance.yahoo.com/news/j-j-arrowhead-gene-silencing-115253968.html
1gw
25/9/2018
12:01
Might get my next tranche at 110p by the look of things
volsung
24/9/2018
10:01
Silence Therapeutics will be presenting to investors at the upcoming Proactive One2One Forum on 4th October in Mayfair,London from 6pm. Details here: https://tinyurl.com/yb3j5c7z
aim_trader
11/9/2018
15:09
So much for that then
viku111
10/9/2018
19:49
Fingers crossed for tomorrow then.
1gw
06/9/2018
21:02
It bugged me when he said that the stake in arrowhead didn't mean that SLN was to become an investment vehicle - I was thinking why not? All the talent was in place for just that. My guess is that was seed of boardroom dissent.
djnzloop
06/9/2018
18:48
Well in hindsight it does make me wonder if a board-level disagreement over what to do with the arwr stake might have led eventually to Ali's departure.
1gw
06/9/2018
18:27
I think it was about 10 million invested .. times 10 at today's rate.Enough to make a CEO run for the hills
djnzloop
06/9/2018
15:52
ARWR up about 40% at the moment and crossed $20 earlier. That would have been well over a 10-bagger for SLN if they'd held wouldn't it? Maybe we can hope to catch some of the upbeat sentiment. hTtps://www.nasdaq.com/article/arrowhead-pharmaceuticals-inc-arwr-has-risen-to-a-new-high-on-study-data-20180906-00725 hTtps://uk.finance.yahoo.com/news/arrowhead-presents-aro-hbv-clinical-113000104.html
1gw
06/9/2018
13:56
Perhaps some buying in anticipation of a positive update on the litigation with the half-year results on Tuesday? Conference call for analysts scheduled for that day.
1gw
06/9/2018
10:28
Some nice crosses appearing on the charts. Bodes well
volsung
30/8/2018
18:54
Spend 20% of their Cash on SLN and i'd be happy enough.
frndlyfire
30/8/2018
15:11
Settling the patent dispute.
waterloo01
30/8/2018
15:06
Ticking for?
viku111
30/8/2018
11:35
The clock is now ticking..... htTp://investors.alnylam.com/news-releases/news-release-details/alnylam-receives-approval-onpattrotm-patisiran-europe Edit: As of the most recent Alnylam accounts they had $1.5bn in cash.
waterloo01
23/8/2018
18:00
Thanks for the info both.
1gw
23/8/2018
17:00
Dirk's been around, and often a lone RNai voice for many years. Doesn't always get it right but he knows the companies in this space well.
waterloo01
23/8/2018
16:31
This guy calls himself the RNAiAnalsyt - and his speculation is below. Dirk Haussecker ‏ @RNAiAnalyst Aug 20 More Dirk Haussecker Retweeted Volker Schulz $SLN stock up 17%...settlement in $ALNY to be announced on official EU approval?
frndlyfire
23/8/2018
14:51
All to do with ALNY and getting the 1st RNai approval and that tSLN have a claim on that and other patents. It would a sensible move from them to just buy SLN or they will be in patent disputes for years.
waterloo01
23/8/2018
14:47
Should dispense with their senior executives more often. Works every time!
callumross
23/8/2018
14:47
Doesn't usually move like this. Summink's up
djnzloop
23/8/2018
14:37
Back to 150 bid, just like that. Very nice, but what's it all about? Just low volume summer trading or something else?
1gw
Chat Pages: Latest  2026  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  Older
Your Recent History
LSE
SLN
Silence Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191122 18:19:53